M&A activity in health care remained steady for the second quarter of 2003. A total of 222 transactions were announced in 13 sectors of the health care industry. This represents a 2% decline from the 227 deals in Q1:03, and a 7% decline from the 238 deals in the year-ago period.
The contribution of each sector, as well as its comparison with prior periods, is presented in the table below.
The four sectors of the health care technology segment announced a combined total of 135 deals, or 61% of the overall total. This represents a small increase of three percentage points over the technology segment’s 58% share in Q1:03, but an 18 percentage point gain over Q2:02’s 43% share.
During Q2:03, the three most active sectors were Medical Devices (45 deals), Pharmaceuticals (39) and Biotechnology (35); together these three accounted for 54% of the quarter’s total 222 transactions. This figure virtually matches the corresponding one in Q1:03 when the same three sectors captured 53% of the total deal volume.
By contrast, all sectors of the health care services segment except Long-Term Care and “Other” languished in single digits. For the third quarter running, Long-Term Care posted the greatest number of deals in the services segment, with each quarter exceeding 20 transactions.
Like this article?
Get the entire issue FREE when you sign up for a no-obligation two-month trial subscription. Click here to sign up.